March 10, 2016 — Paxeramed Corp. has announced the release of version 2.0 of its patient engagement app CarePassport ...
March 10, 2016 — 4Tech Inc. announced that it has secured $29 million in an oversubscribed series B financing, which ...
St. Jude Medical Inc. announced CE Mark approval for magnetic resonance (MR) conditional labeling for 1.5 T scans for the company’s Nanostim leadless pacemaker. With the approval, throughout Europe both existing patients implanted with a Nanostim leadless pacemaker and new patients receiving the device in the future can safely undergo full-body MRI diagnostic scans.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Managing inventory in the procedural area is often a challenge that creates substantial waste and inefficiency that ...
March 9, 2016 — New research suggests a high coronary artery calcium score puts people at greater risk not only for ...
Japanese business magazine Nikkei Asian Review reported Wednesday that Canon has been named the winning bidder for the acquisition of Toshiba Medical Systems. The winning bid was reportedly valued at $6.21 billion.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The Louis and Peaches Owen Heart Hospital at Trinity Mother Frances Hospitals and Clinics is providing its vascular surgery patients with fast, high-quality ultrasound exams using two new Aplio 500 Platinum systems from Toshiba America Medical Systems Inc.
John Showalter, M.D., CHIO, University of Mississippi Medical Center, explains how he created population health ...
Merit Medical Systems Inc. announced that the first ThinkRadial course to be held at its European headquarters in Maastricht, the Netherlands, took place Feb. 25-26. The ThinkRadial program serves to educate and train interventional cardiologists, interventional radiologists and vascular surgeons around the world about using the radial artery, as an alternative to the femoral artery, to gain access for interventional procedures.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Lumedx Corp. announced that it has been selected to provide a cardiovascular information system (CVIS) for four CoxHealth hospitals. Based in Springfield, Mo., CoxHealth chose the Lumedx HealthView platform for its robust analytics software and because the company offers the ability to integrate disparate systems with a single sign-on.
March 8, 2016 — phenox GmbH announced participation in the SITS Open clinical trial, where pREset and pREset LITE ...
Fluoroscopy makes guiding a catheter through a blood vessel possible. However, fluoroscopy, a form of real-time moving X-ray, also exposes the patient to radiation. Now, a University of Missouri School of Medicine researcher has evaluated technology that may be used to replace fluoroscopy, eliminating the need for X-ray during cardiac ablation procedures.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Biotronik announced publication of results from the BIOSCIENCE trial in the journal EuroIntervention. The study’s authors suggest the Orsiro hybrid drug-eluting stent (DES) may have an advantage over Xience Prime/Xpedition in treating ST-segment elevation myocardial infarction (STEMI) patients. STEMI is a potentially fatal type of heart attack caused by a prolonged obstruction of blood supply in the heart. Every year nearly 250,000 people experience STEMI heart attacks.
Women undergoing transcatheter aortic valve replacement (TAVR) have better survival rates than men at one year, according to a study published in Annals of Internal Medicine. These results are the opposite of those seen in surgical aortic valve replacement (SAVR), for which female sex has been shown to be associated with poorer outcomes.
At the Houston Aortic Symposium, W. L. Gore & Associates, Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) approval of the Gore Excluder Iliac Branch Endoprosthesis (IBE). The approval makes it the first off-the-shelf aortic branch device approved in the United States and the only device indicated for the endovascular treatment of common iliac artery aneurysms or aortoiliac aneurysms.